Summary

In-vitro Inflammatory Bowel Disease Diagnostics Market – Scope of Report
TMR’s report on the global in-vitro inflammatory bowel disease diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global in-vitro inflammatory bowel disease diagnostics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro inflammatory bowel disease diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in-vitro inflammatory bowel disease diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro inflammatory bowel disease diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro inflammatory bowel disease diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro inflammatory bowel disease diagnostics market.

The report delves into the competitive landscape of the global in-vitro inflammatory bowel disease diagnostics market. Key players operating in the global in-vitro inflammatory bowel disease diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro inflammatory bowel disease diagnostics market profiled in this report.

Key Questions Answered in Global in-vitro inflammatory bowel disease diagnostics Market Report
• What is the sales/revenue generated by in-vitro inflammatory bowel disease diagnostics across all regions during the forecast period?
• What are the opportunities in the global in-vitro inflammatory bowel disease diagnostics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

In-vitro Inflammatory Bowel Disease Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global in-vitro inflammatory bowel disease diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro inflammatory bowel disease diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro inflammatory bowel disease diagnostics market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global In-Vitro Inflammatory Bowel Disease Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, 2020 - 2034
5. Key Insights
5.1. Key Product/Brand Analysis
5.2. Technological Outlook
5.3. Disease Prevalence and Incidence Rate of Colorectal Cancer in Europe
5.4. Overview: National Screening Program Scenario
5.5. Regulatory Scenario in Europe
6. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2020 - 2034
6.3.1. Assays/Biomarker
6.3.1.1. Calprotectin
6.3.1.2. Lactoferrin
6.3.1.3. Bile Acids
6.3.1.4. H. pylori SA
6.3.1.5. Pancreatic Elastase
6.3.1.6. Others
6.3.2. Analyzers
6.4. Market Attractiveness By Product
7. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Testing Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Testing Type, 2020 - 2034
7.3.1. Laboratory-based Testing
7.3.2. Point-of-Care (POC) Testing
7.3.3. Self-testing Kits
7.4. Market Attractiveness By Testing Type
8. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2020 - 2034
8.3.1. Diagnostic Laboratories
8.3.2. Hospitals
8.3.3. Others (Homecare Testing & Research Institutes etc.)
8.4. Market Attractiveness By End-user
9. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2020 - 2034
10.2.1. Assays/Biomarker
10.2.1.1. Calprotectin
10.2.1.2. Lactoferrin
10.2.1.3. Bile Acids
10.2.1.4. H. pylori SA
10.2.1.5. Pancreatic Elastase
10.2.1.6. Others
10.2.2. Analyzers
10.3. Market Value Forecast By Testing Type, 2020 - 2034
10.3.1. Laboratory-based Testing
10.3.2. Point-of-Care (POC) Testing
10.3.3. Self-testing Kits
10.4. Market Value Forecast By End-user, 2020 - 2034
10.4.1. Diagnostic Laboratories
10.4.2. Hospitals
10.4.3. Others (Homecare Testing & Research Institutes etc.)
10.5. Market Value Forecast By Country, 2020 - 2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Testing Type
10.6.3. By End-user
10.6.4. By Country
11. Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2020 - 2034
11.2.1. Assays/Biomarker
11.2.1.1. Calprotectin
11.2.1.2. Lactoferrin
11.2.1.3. Bile Acids
11.2.1.4. H. pylori SA
11.2.1.5. Pancreatic Elastase
11.2.1.6. Others
11.2.2. Analyzers
11.3. Market Value Forecast By Testing Type, 2020 - 2034
11.3.1. Laboratory-based Testing
11.3.2. Point-of-Care (POC) Testing
11.3.3. Self-testing Kits
11.4. Market Value Forecast By End-user, 2020 - 2034
11.4.1. Diagnostic Laboratories
11.4.2. Hospitals
11.4.3. Others (Homecare Testing & Research Institutes etc.)
11.5. Market Value Forecast By Country, 2020 - 2034
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Testing Type
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2020 - 2034
12.2.1. Assays/Biomarker
12.2.1.1. Calprotectin
12.2.1.2. Lactoferrin
12.2.1.3. Bile Acids
12.2.1.4. H. pylori SA
12.2.1.5. Pancreatic Elastase
12.2.1.6. Others
12.2.2. Analyzers
12.3. Market Value Forecast By Testing Type, 2020 - 2034
12.3.1. Laboratory-based Testing
12.3.2. Point-of-Care (POC) Testing
12.3.3. Self-testing Kits
12.4. Market Value Forecast By End-user, 2020 - 2034
12.4.1. Diagnostic Laboratories
12.4.2. Hospitals
12.4.3. Others (Homecare Testing & Research Institutes etc.)
12.5. Market Value Forecast By Country, 2020 - 2034
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Testing Type
12.6.3. By End-user
12.6.4. By Country
13. Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2020 - 2034
13.2.1. Assays/Biomarker
13.2.1.1. Calprotectin
13.2.1.2. Lactoferrin
13.2.1.3. Bile Acids
13.2.1.4. H. pylori SA
13.2.1.5. Pancreatic Elastase
13.2.1.6. Others
13.2.2. Analyzers
13.3. Market Value Forecast By Testing Type, 2020 - 2034
13.3.1. Laboratory-based Testing
13.3.2. Point-of-Care (POC) Testing
13.3.3. Self-testing Kits
13.4. Market Value Forecast By End-user, 2020 - 2034
13.4.1. Diagnostic Laboratories
13.4.2. Hospitals
13.4.3. Others (Homecare Testing & Research Institutes etc.)
13.5. Market Value Forecast By Country, 2020 - 2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Testing Type
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product, 2020 - 2034
14.2.1. Assays/Biomarker
14.2.1.1. Calprotectin
14.2.1.2. Lactoferrin
14.2.1.3. Bile Acids
14.2.1.4. H. pylori SA
14.2.1.5. Pancreatic Elastase
14.2.1.6. Others
14.2.2. Analyzers
14.3. Market Value Forecast By Testing Type, 2020 - 2034
14.3.1. Laboratory-based Testing
14.3.2. Point-of-Care (POC) Testing
14.3.3. Self-testing Kits
14.4. Market Value Forecast By End-user, 2020 - 2034
14.4.1. Diagnostic Laboratories
14.4.2. Hospitals
14.4.3. Others (Homecare Testing & Research Institutes etc.)
14.5. Market Value Forecast By Country, 2020 - 2034
14.5.1. GCC
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Testing Type
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Global Dental Bearings Market : Company Share Analysis (2023)
15.2. Company Profiles
15.2.1. F. Hoffmann-La Roche AG
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. Thermo Fisher Scientific Inc.
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Abbott Laboratories
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Sentinel Diagnostic
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. BTNX Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. Immundiagnostik AG
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. Quest Diagnostics
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Sysmex Europe SE
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. Diasorin S.p.A
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. BioSystems S.A.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Financial Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
15.2.11. QuidelOrtho Corporation
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Financial Overview
15.2.11.4. SWOT Analysis
15.2.11.5. Strategic Overview
15.2.12. Other Prominent Players
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Financial Overview
15.2.12.4. SWOT Analysis
15.2.12.5. Strategic Overview